doi: 10.1016/0014-2964(81)90027-x.
Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute
- PMID: 6894902
- DOI: 10.1016/0014-2964(81)90027-x
Item in Clipboard
Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute
Eur J Cancer (1965).
1981 Feb.
No abstract available
Similar articles
-
A prospective screening program: current screening and its status.Recent Results Cancer Res. 1981;76:176-91. doi: 10.1007/978-3-642-81565-2_15. Recent Results Cancer Res. 1981. PMID: 7232850 No abstract available.
-
Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute.Cancer Treat Rev. 1980 Dec;7(4):167-76. doi: 10.1016/s0305-7372(80)80032-6. Cancer Treat Rev. 1980. PMID: 7214373 No abstract available.
-
The new NCI screen and its implications for clinical evaluation.Recent Results Cancer Res. 1980;70:5-20. doi: 10.1007/978-3-642-81392-4_2. Recent Results Cancer Res. 1980. PMID: 7355249 No abstract available.
-
Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.Adv Pharmacol Chemother. 1984;20:1-20. doi: 10.1016/s1054-3589(08)60263-x. Adv Pharmacol Chemother. 1984. PMID: 6398966 Review. No abstract available.
-
Usefulness and limitations of murine tumor models for the identification of new antitumor agents.Antibiot Chemother (1971). 1980;28:1-7. doi: 10.1159/000386050. Antibiot Chemother (1971). 1980. PMID: 6998358 Review.
Cited by
-
Anticancer Activity of Novel Plant Extracts and Compounds from Adenosma bracteosum (Bonati) in Human Lung and Liver Cancer Cells.Molecules. 2020 Jun 24;25(12):2912. doi: 10.3390/molecules25122912. Molecules. 2020. PMID: 32599892 Free PMC article.
-
Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.Invest New Drugs. 1991 May;9(2):137-48. doi: 10.1007/BF00175081. Invest New Drugs. 1991. PMID: 1874598
-
Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.Br J Cancer. 1986 Jul;54(1):33-42. doi: 10.1038/bjc.1986.149. Br J Cancer. 1986. PMID: 3730255 Free PMC article.
-
Is the P388 murine tumor no longer adequate as a drug discovery model?Invest New Drugs. 1987;5(1):3-20. doi: 10.1007/BF00217664. Invest New Drugs. 1987. PMID: 3298130 Review. No abstract available.
-
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin.Cancer Chemother Pharmacol. 1988;21(3):251-4. doi: 10.1007/BF00262780. Cancer Chemother Pharmacol. 1988. PMID: 3359560
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources